# Biovectra, Inc. – FDA Inspection, Feb 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/biovectra-inc/414fec90-8c34-4acb-8363-3fd7049d3ec8
Source feed: FDA_Inspections

> FDA inspection 1008484 of Biovectra, Inc., February 17, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008484
- Company Name: Biovectra, Inc.
- Inspection Date: 2017-02-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1239225 - 2024-04-19
- FDA Inspection 1180023 - 2022-08-26
- FDA Inspection 927704 - 2015-04-17
- FDA Inspection 847468 - 2013-08-08
- FDA Inspection 684938 - 2010-08-25

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/stacie-a-woods/75a78a01-422e-4c6a-b7ac-b858354264ae)
- [Investigator](https://www.keypedia.com/people/tonya-r-johnson/403d3eb6-758b-4c57-80cf-901359382588)

Company: https://www.keypedia.com/companies/biovectra-inc/1e29a998-319e-49cb-bee2-bacea2c620ef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
